DuPont (Dymel Pharma Business)
M&A
STATUS
M&A
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Developer of pharmaceuticals. The company offers medicines used in the treatment of HIV, cardiovascular disease, central nervous system disorders, cancer and inflammatory diseases.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Office
- 1007 Market Street
- Wilmington, DE 19898
- United States
DuPont (Dymel Pharma Business) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore DuPont (Dymel Pharma Business)‘s full profile, request access.
Request full access to PitchBook